Variant report

Variant	nsv911809
Chromosome Location	chr19:43233048-43374601
allele	n/a
Outlinks	Ensembl UCSC

Chromatin state
Related regulatory elements
Target genes
Other information

TF binding
region (count:1952)
CpG islands
(count:1041)
Chromatin interactive
region (count:7)
LncRNA
region (count:22)
Mature miRNA
region (count: 0)
miRNA target
sites (count:0)

(count:1952 , 50 per page) page: 1 2 3 4 5 6 7 ... 40

No.	Transcrition factor	Chromosome Location	Cell Line	Cell type	Cell Stage	Matched TF binding sites
1	ATF3	chr19:43335307-43336092	A549	lung:	n/a	n/a
2	ATF3	chr19:43336336-43336928	A549	lung:	n/a	n/a
3	ATF3	chr19:43335349-43336094	A549	lung:	n/a	n/a
4	ATF3	chr19:43336349-43336838	A549	lung:	n/a	n/a
5	ATF3	chr19:43355412-43355889	A549	lung:	n/a	n/a
6	ATF3	chr19:43355048-43355947	A549	lung:	n/a	n/a
7	BATF	chr19:43271446-43271728	GM12878	blood:	n/a	n/a
8	BATF	chr19:43302238-43302533	GM12878	blood:	n/a	chr19:43302344-43302355
9	BATF	chr19:43361555-43361754	GM12878	blood:	n/a	n/a
10	BATF	chr19:43246213-43246502	GM12878	blood:	n/a	n/a
11	BCL3	chr19:43297507-43298116	A549	lung:	n/a	n/a
12	BCL3	chr19:43323095-43323355	GM12878	blood:	n/a	n/a
13	BCL3	chr19:43336972-43337663	A549	lung:	n/a	n/a
14	BCL3	chr19:43354946-43356043	A549	lung:	n/a	n/a
15	BCL3	chr19:43335292-43335990	A549	lung:	n/a	chr19:43335602-43335611 chr19:43335603-43335612
16	BCL3	chr19:43354910-43356058	A549	lung:	n/a	n/a
17	BCL3	chr19:43336292-43336877	A549	lung:	n/a	n/a
18	BCL3	chr19:43335242-43336126	A549	lung:	n/a	chr19:43335602-43335611 chr19:43335603-43335612
19	BCL3	chr19:43336159-43337656	A549	lung:	n/a	chr19:43336227-43336234
20	BHLHE40	chr19:43355572-43355890	A549	lung:	n/a	n/a
21	BRCA1	chr19:43297623-43297950	Hela-S3	cervix:	n/a	n/a
22	BRCA1	chr19:43265411-43265577	Hela-S3	cervix:	n/a	n/a
23	BRCA1	chr19:43355288-43355847	Hela-S3	cervix:	n/a	n/a
24	CEBPB	chr19:43324277-43324368	A549	lung:	n/a	n/a
25	CEBPB	chr19:43239908-43240549	Hela-S3	cervix:	n/a	n/a
26	CEBPB	chr19:43337171-43337381	A549	lung:	n/a	n/a
27	CEBPB	chr19:43329315-43329373	K562	blood:	n/a	chr19:43329341-43329352
28	CEBPB	chr19:43355051-43355897	A549	lung:	n/a	n/a
29	CEBPB	chr19:43328170-43328414	A549	lung:	n/a	chr19:43328257-43328268
30	CEBPB	chr19:43265127-43265827	Hela-S3	cervix:	n/a	n/a
31	CEBPB	chr19:43339077-43339322	A549	lung:	n/a	n/a
32	CEBPB	chr19:43328156-43328419	IMR90	lung:	n/a	chr19:43328257-43328268
33	CEBPB	chr19:43326599-43326799	A549	lung:	n/a	n/a
34	CEBPB	chr19:43297691-43297991	Hela-S3	cervix:	n/a	n/a
35	CEBPB	chr19:43328228-43328417	HepG2	liver:	n/a	chr19:43328257-43328268
36	CEBPB	chr19:43335392-43336031	A549	lung:	n/a	n/a
37	CEBPB	chr19:43297755-43297993	A549	lung:	n/a	n/a
38	CEBPB	chr19:43345870-43346046	IMR90	lung:	n/a	n/a
39	CEBPB	chr19:43339173-43339354	Hela-S3	cervix:	n/a	n/a
40	CEBPB	chr19:43336488-43336863	Hela-S3	cervix:	n/a	n/a
41	CEBPB	chr19:43335339-43335868	A549	lung:	n/a	n/a
42	CEBPB	chr19:43329190-43329511	A549	lung:	n/a	chr19:43329341-43329352
43	CEBPB	chr19:43265183-43265848	IMR90	lung:	n/a	n/a
44	CEBPB	chr19:43337225-43337426	IMR90	lung:	n/a	n/a
45	CEBPB	chr19:43328208-43328426	Hela-S3	cervix:	n/a	chr19:43328257-43328268
46	CEBPB	chr19:43354986-43356104	A549	lung:	n/a	n/a
47	CEBPB	chr19:43324137-43324522	IMR90	lung:	n/a	n/a
48	CEBPB	chr19:43337158-43337425	Hela-S3	cervix:	n/a	n/a
49	CEBPB	chr19:43239891-43240238	IMR90	lung:	n/a	n/a
50	CEBPB	chr19:43335425-43335832	MCF-7	breast:	n/a	n/a

(count:1041 , 50 per page) page: 1 2 3 4 5 6 7 ... 21

No.	Chromosome Location	Cell Line	Cell type	Cell Stage
1	chr19:43360229-43360279	HIPEpiC	eye:	n/a
2	chr19:43257346-43257396	Hepatocyte	liver:	n/a
3	chr19:43244635-43244685	ProgFib	skin:	n/a
4	chr19:43271058-43271108	PFSK-1	brain:	n/a
5	chr19:43360229-43360279	HIPEpiC	eye:	n/a
6	chr19:43257346-43257396	Hepatocyte	liver:	n/a
7	chr19:43244635-43244685	ProgFib	skin:	n/a
8	chr19:43271058-43271108	PFSK-1	brain:	n/a
9	chr19:43245860-43245910	HRCEpiC	kidney:	n/a
10	chr19:43359870-43359920	Hepatocyte	liver:	n/a
11	chr19:43271004-43271054	ProgFib	skin:	n/a
12	chr19:43269877-43269927	RPTEC	kidney:	n/a
13	chr19:43360229-43360279	U87	brain:	n/a
14	chr19:43244680-43244730	GM19239	blood:	n/a
15	chr19:43265778-43265828	HNPCEpiC	eye:	n/a
16	chr19:43265778-43265828	GM12891	blood:	n/a
17	chr19:43257346-43257396	Caco-2	colon:	n/a
18	chr19:43244635-43244685	HNPCEpiC	eye:	n/a
19	chr19:43271112-43271162	HCM	heart:	n/a
20	chr19:43359870-43359920	HRE	kidney:	n/a
21	chr19:43265778-43265828	BJ	skin:	n/a
22	chr19:43361218-43361268	Hepatocyte	liver:	n/a
23	chr19:43355659-43355709	HCM	heart:	n/a
24	chr19:43257346-43257396	AG09309	skin:	n/a
25	chr19:43271004-43271054	SAEC	small airway:	n/a
26	chr19:43245860-43245910	HMEC	breast:	n/a
27	chr19:43359870-43359920	SK-N-SH	brain:	n/a
28	chr19:43355659-43355709	HPAEpiC	pulmonary alveolar:	n/a
29	chr19:43240516-43240566	HNPCEpiC	eye:	n/a
30	chr19:43240516-43240566	SK-N-SH	brain:	n/a
31	chr19:43359870-43359920	HCF	heart:	n/a
32	chr19:43355659-43355709	HIPEpiC	eye:	n/a
33	chr19:43271004-43271054	Hepatocyte	liver:	n/a
34	chr19:43271004-43271054	HL-60	blood:	n/a
35	chr19:43271058-43271108	Hela-S3	cervix:	n/a
36	chr19:43271004-43271054	CMK	blood:	n/a
37	chr19:43245921-43245971	PFSK-1	brain:	n/a
38	chr19:43245921-43245971	Caco-2	colon:	n/a
39	chr19:43245860-43245910	NH-A	brain:	n/a
40	chr19:43257346-43257396	ProgFib	skin:	n/a
41	chr19:43271058-43271108	HCPEpiC	choroid plexus:	n/a
42	chr19:43271112-43271162	HPAEpiC	pulmonary alveolar:	n/a
43	chr19:43257346-43257396	HRCEpiC	kidney:	n/a
44	chr19:43360229-43360279	ovcar-3	ovarian:	n/a
45	chr19:43271004-43271054	MCF-7	breast:	n/a
46	chr19:43245860-43245910	HRE	kidney:	n/a
47	chr19:43271004-43271054	BJ	skin:	n/a
48	chr19:43271058-43271108	GM12878	blood:	n/a
49	chr19:43361218-43361268	AG04449	skin:	fetal
50	chr19:43240516-43240566	HPAEpiC	pulmonary alveolar:	n/a

(count:7 , 50 per page) page: 1

No.	Distal block	Cell Line	Cell type
1	chr19:43297087..43297875-chr19:43423005..43423976,2	MCF-7	breast:
2	chr19:43197626..43198528-chr19:43245881..43246809,2	MCF-7	breast:
3	chr19:43139154..43139986-chr19:43246322..43246897,2	MCF-7	breast:
4	chr19:43197633..43198568-chr19:43280847..43281639,2	K562	blood:
5	chr19:43265768..43266290-chr19:43769932..43770473,2	MCF-7	breast:
6	chr19:43197647..43198196-chr19:43280850..43281744,2	MCF-7	breast:
7	chr19:43197619..43198590-chr19:43246174..43246898,3	MCF-7	breast:

(count:22 , 50 per page) page: 1

No.	lncRNA name	Chromosome Location	lncRNA alias
1	lnc-PSG3-1	chr19:43256843-43257528	NONHSAT066566
2	lnc-PSG6-3	chr19:43370618-43371302	NONHSAT066572
3	lnc-PSG1-1	chr19:43343520-43343530	NONHSAT146988
4	lnc-PSG1-1	chr19:43343708-43343916	NONHSAT066571
5	lnc-PSG6-3	chr19:43372253-43372507	NONHSAT066572
6	lnc-PSG6-3	chr19:43372908-43374797	NONHSAT066572
7	lnc-PSG8-1	chr19:43290505-43290747	NONHSAT066567
8	lnc-PSG1-1	chr19:43349168-43349446	NONHSAT146988
9	lnc-PSG1-1	chr19:43348511-43348765	NONHSAT146988
10	lnc-PSG1-1	chr19:43349168-43349446	NONHSAT066571
11	lnc-PSG1-1	chr19:43358101-43358466	NONHSAT066571
12	lnc-PSG1-1	chr19:43358101-43358466	NONHSAT146988
13	lnc-PSG8-1	chr19:43285358-43285449	NONHSAT066567
14	lnc-PSG1-1	chr19:43359708-43359870	NONHSAT066571
15	lnc-PSG1-1	chr19:43341149-43341534	NONHSAT066571
16	lnc-PSG1-1	chr19:43341149-43341602	NONHSAT066570
17	lnc-PSG8-1	chr19:43289879-43290117	NONHSAT066567
18	lnc-PSG3-1	chr19:43258485-43260276	NONHSAT066566
19	lnc-PSG1-1	chr19:43359708-43359870	NONHSAT146988
20	lnc-PSG1-1	chr19:43348511-43348765	NONHSAT066571
21	lnc-PSG1-1	chr19:43343447-43343530	NONHSAT066571
22	lnc-PSG1-1	chr19:43343708-43343916	NONHSAT146988

No data

Variant related genes	Relation type
PSG8	TF binding region
ENSG00000225877	TF binding region
CEACAMP6	TF binding region
PSG3	TF binding region
PSG10P	TF binding region
PSG8	CpG island
ENSG00000225877	CpG island
CEACAMP6	CpG island
PSG3	CpG island
PSG10P	CpG island
ENSG00000170848	chromatin interactions

Extended variants
information (count: 7904 )
Associated
traits (count: 65 )

Variant overlapped rSNPs/rCNVs (count:7904 , 50 per page) page: 1 2 3 4 5 6 7 ... 159

No.	Variant name	Chromosome position	Chromatin state	Related regulatory elements	Target genes	Extended variants	Associated traits
1	rs10407819	chr19:43233048-43233049	Enhancers Weak transcription	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
2	rs574668991	chr19:43233053-43233054	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
3	rs543670210	chr19:43233056-43233057	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
4	rs563495952	chr19:43233075-43233076	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
5	rs193107591	chr19:43233091-43233092	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
6	rs565488443	chr19:43233104-43233105	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
7	rs1063008	chr19:43233106-43233107	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
8	rs546129715	chr19:43233129-43233130	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
9	rs16976106	chr19:43233134-43233135	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
10	rs139058212	chr19:43233138-43233139	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
11	rs528534934	chr19:43233221-43233222	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
12	rs112146170	chr19:43233222-43233223	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
13	rs554611430	chr19:43233227-43233228	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
14	rs371067181	chr19:43233229-43233230	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
15	rs568578165	chr19:43233265-43233266	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
16	rs17420676	chr19:43233284-43233285	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
17	rs550724628	chr19:43233289-43233290	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
18	rs200705363	chr19:43233292-43233293	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
19	rs570717542	chr19:43233293-43233294	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
20	rs374603147	chr19:43233295-43233296	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
21	rs77287970	chr19:43233300-43233301	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
22	rs141177217	chr19:43233301-43233302	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
23	rs78863189	chr19:43233304-43233305	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
24	rs17405169	chr19:43233310-43233311	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
25	rs139115178	chr19:43233315-43233316	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
26	rs367635956	chr19:43233320-43233321	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
27	rs201016169	chr19:43233328-43233329	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
28	rs149820484	chr19:43233329-43233330	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
29	rs534647406	chr19:43233346-43233347	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
30	rs374575970	chr19:43233351-43233352	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
31	rs554345233	chr19:43233372-43233373	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
32	rs529999645	chr19:43233389-43233390	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
33	rs146855604	chr19:43233390-43233391	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
34	rs141810038	chr19:43233397-43233398	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
35	rs144526077	chr19:43233404-43233405	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
36	rs200238055	chr19:43233419-43233420	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
37	rs202207386	chr19:43233421-43233422	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
38	rs201802772	chr19:43233426-43233427	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
39	rs146535064	chr19:43233443-43233444	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
40	rs201063467	chr19:43233452-43233453	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
41	rs200069263	chr19:43233453-43233454	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
42	rs557153041	chr19:43233484-43233485	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
43	rs577115886	chr19:43233488-43233489	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
44	rs1065179	chr19:43233498-43233499	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
45	rs545778067	chr19:43233506-43233507	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
46	rs200882874	chr19:43233536-43233537	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
47	rs376324148	chr19:43233555-43233556	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
48	rs374324013	chr19:43233568-43233569	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
49	rs528463261	chr19:43233582-43233583	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
50	rs189019853	chr19:43233633-43233634	Weak transcription Genic enhancers	n/a	n/a	Overlapped CNVs	n/a

Variant related diseases (count:65)

Disease	PMID	Source
Myelodysplastic syndrome	17634407	CNVD
Acute lymphoblastic leukemia	22237106	CNVD
Chordoma	21602918	CNVD
Ewing''s sarcoma	21437220	CNVD
Glioblastoma multiforme	21080181	CNVD
Chronic lymphocytic leukemia	21546498	CNVD
Cancer	21637783	CNVD
Retinoblastoma	21504564	CNVD
Medulloblastoma	21979893	CNVD
Ovarian cancer	21720365	CNVD
Cancer	20164919	CNVD
Thoracic aortic aneurysm	21092924	CNVD
T-cell prolymphocytic leukemia	19278963	CNVD
Prostate cancer	18632612	CNVD
Autism	22495311	CNVD
Adenoid cystic carcinoma	18698036	CNVD
Ductal carcinoma	22052326	CNVD
Congenital nephrotic syndrome	18421352	CNVD
Astrocytoma	17934521	CNVD
Leukemia	17361228	CNVD
Adenoid cystic carcinoma	17372589	CNVD
Breast cancer	21858162	CNVD
Breast cancer	17603634	CNVD
Glioma	21971842	CNVD
Esophageal squamous carcinoma	21637470	CNVD
Endometrial cancer	22040021	CNVD
Astrocytoma	17387387	CNVD
Breast cancer	21264507	CNVD
Oligodendroglial tumors	17285580	CNVD
renal disease	20603712	CNVD
Salivary gland adenoid cystic carcinoma	17545515	CNVD
Breast cancer	16608533	CNVD
Neuroblastoma	18923191	CNVD
Breast cancer	21364760	CNVD
Invasive pancreatic ductal carcinoma	18765526	CNVD
Rhabdomyosarcoma	16790082	CNVD
Chordoma	18071362	CNVD
Urothelial carcinoma	21177765	CNVD
small cell lung cancer	20016488	CNVD
Wilms tumour	21544195	CNVD
Acute lymphoblastic leukemia	20067559	CNVD
Ovarian neoplasms	16753589	CNVD
Malignant fibrous histiocytomas	21085701	CNVD
Metanephric adenoma	20802469	CNVD
Acute myeloid leukemia	16864856	CNVD
Bladder cancer	21909424	CNVD
Medulloblastoma	16783165	CNVD
Gastric cancer	18160780	CNVD
Hepatocellular carcinoma	16750200	CNVD
Basal cell lymphoma	19029149	CNVD
Breast cancer	20409316	CNVD
Diffuse large b-cell lymphoma	19029149	CNVD
Multiple myeloma	16616336	CNVD
Renal cell carcinoma	18765545	CNVD
Acute myeloid leukemia	20729466	CNVD
Lung cancer	18438408	CNVD
Ovarian clear cell carcinoma	19293255	CNVD
Astrocytoma	22246337	CNVD
Ovarian cancer	22174824	CNVD
Multiple myeloma	17550852	CNVD
Breast cancer	22522925	CNVD
Breast cancer	21509527	CNVD
Cancer	20164920	CNVD
Pancreatic cancer	17952125	CNVD
Ependymoma	20639864	CNVD

Chromatin state (count:566 , 50 per page) page: 1 2 3 4 5 6 7 ... 12

No.	Chromosome Location	Chromatin state	Cell line	Tissue
1	chr19:43229200-43233600	Weak transcription	Placenta	Placenta
2	chr19:43232400-43233600	Enhancers	Brain Hippocampus Middle	brain
3	chr19:43232600-43233200	Enhancers	Brain Cingulate Gyrus	brain
4	chr19:43232800-43233200	Enhancers	Brain Substantia Nigra	brain
5	chr19:43233200-43236800	Weak transcription	Brain Substantia Nigra	brain
6	chr19:43233600-43233800	Genic enhancers	Placenta	Placenta
7	chr19:43233800-43234200	Weak transcription	Placenta	Placenta
8	chr19:43234200-43235000	Genic enhancers	Placenta	Placenta
9	chr19:43235000-43236600	Weak transcription	Placenta	Placenta
10	chr19:43236600-43237600	Genic enhancers	Placenta	Placenta
11	chr19:43236800-43237200	Active TSS	Brain Substantia Nigra	brain
12	chr19:43237600-43238400	Weak transcription	Placenta	Placenta
13	chr19:43238400-43241600	Active TSS	Placenta	Placenta
14	chr19:43239000-43240400	Enhancers	NHDF-Ad	bronchial
15	chr19:43239000-43242200	Enhancers	Osteobl	bone
16	chr19:43239000-43242800	Enhancers	Breast Myoepithelial Primary Cells	Breast
17	chr19:43239200-43242000	Enhancers	Bone Marrow Derived Cultured Mesenchymal Stem Cells	Bone marrow
18	chr19:43239400-43240400	Enhancers	Foreskin Fibroblast Primary Cells skin01	Skin
19	chr19:43239400-43242000	Enhancers	Breast variant Human Mammary Epithelial Cells (vHMEC)	Breast
20	chr19:43239400-43242200	Enhancers	Adipose Derived Mesenchymal Stem Cell Cultured Cells	ES cell derived
21	chr19:43239400-43242400	Enhancers	Foreskin Keratinocyte Primary Cells skin02	Skin
22	chr19:43239400-43242400	Enhancers	HMEC	breast
23	chr19:43239400-43242800	Enhancers	Fetal Adrenal Gland	Adrenal Gland
24	chr19:43239800-43240400	Enhancers	IMR90 fetal lung fibroblasts Cell Line	lung
25	chr19:43239800-43242000	Enhancers	NH-A	brain
26	chr19:43239800-43242600	Enhancers	NHEK	skin
27	chr19:43240000-43240200	Enhancers	Foreskin Fibroblast Primary Cells skin02	Skin
28	chr19:43240000-43240200	Enhancers	HSMM	muscle
29	chr19:43240000-43240200	Enhancers	NHLF	lung
30	chr19:43240000-43241000	Enhancers	Muscle Satellite Cultured Cells	--
31	chr19:43240000-43241200	Enhancers	hESC Derived CD56+ Mesoderm Cultured Cells	ES cell derived
32	chr19:43240000-43242000	Enhancers	Foreskin Keratinocyte Primary Cells skin03	Skin
33	chr19:43240200-43241000	Weak transcription	NHLF	lung
34	chr19:43240200-43241600	Weak transcription	HSMM	muscle
35	chr19:43240400-43240800	Weak transcription	IMR90 fetal lung fibroblasts Cell Line	lung
36	chr19:43240400-43240800	Weak transcription	NHDF-Ad	bronchial
37	chr19:43240400-43241400	Weak transcription	Foreskin Fibroblast Primary Cells skin01	Skin
38	chr19:43240400-43241800	Weak transcription	Foreskin Fibroblast Primary Cells skin02	Skin
39	chr19:43240800-43242200	Enhancers	NHDF-Ad	bronchial
40	chr19:43240800-43242400	Enhancers	IMR90 fetal lung fibroblasts Cell Line	lung
41	chr19:43241000-43241400	Weak transcription	Muscle Satellite Cultured Cells	--
42	chr19:43241000-43242000	Enhancers	NHLF	lung
43	chr19:43241400-43242000	Enhancers	Foreskin Fibroblast Primary Cells skin01	Skin
44	chr19:43241400-43242200	Enhancers	Muscle Satellite Cultured Cells	--
45	chr19:43241600-43242000	Enhancers	HSMM	muscle
46	chr19:43241600-43243400	Transcr. at gene 5' and 3'	Placenta	Placenta
47	chr19:43241800-43242200	Enhancers	Foreskin Fibroblast Primary Cells skin02	Skin
48	chr19:43242800-43243200	Active TSS	Brain Substantia Nigra	brain
49	chr19:43243400-43244600	Active TSS	Placenta	Placenta
50	chr19:43244400-43244600	Enhancers	iPS DF 19.11 Cell Line	embryonic stem cell

The 2.0 version of rSNPBase

Variant report

Quick Search:

what's new

Quick links